Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of its second startup, DenovAI.
DenovAI will develop an AI-enabled computational biophysics platform that can discover potential antibodies directed toward specific epitopes (the part of an antigen molecule recognized by the immune system to which an antibody attaches...
Copenhagen-based digital health company Dawn Health announced a strategic partnership with pharma giant Novartis to develop a chronic condition management platform.
Under the collaboration, Dawn and Novartis will build remote monitoring and management tools for chronic conditions where they see an unmet need and concerns around disease progression, like multiple sclerosis, hypertension,...
Deidentifying data from wearable devices may not be enough to protect users' privacy, according to a review of studies published in the Lancet Digital Health.
The analysis focused on studies that evaluated whether individuals could be reidentified based on biometric signals from wearables. The researchers included 72 studies in their final review. Most focused on using EEG, ECG and inertial...
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with diabetes and chronic disease management company Diathrive Health to provide lower-cost prescription medication and diabetes testing supplies to Diathrive's members.
Diathrive Health offers individuals and employers personalized coaching via live messaging and video chat, as well as care plans, articles and videos to help manage...
The Digital Medicine Society (DiMe) and a suite of digital health and pharma players partnered to launch a toolkit aimed at improving diversity, equity and inclusion in clinical trials.
The resources include a guide to each step of a digital clinical trial, shared definitions of terms like "diversity" and "equity," a list of different digital tools that could be used and the potential benefits...
Faro Health, which offers software to help researchers design clinical trials, announced last week it had raised $20 million in a round led by General Catalyst.
Participants in the raise include returning investors Section 32, Polaris Partners, Zetta Ventures, and Northpond Ventures. The startup previously scooped up $15 million in Series A funding.
"Faro has developed software that allows rapid...
Tech-enabled clinical trial platform Paradigm announced its launch alongside a $203 million Series A funding round co-led by ARCH Venture Partners and General Catalyst.
F-Prime Capital, LUX Capital, GV, Magnetic Ventures and Mubadala Capital also participated in the round. American Cancer Society's BrightEdge fund was a strategic investor.
The company also announced its acquisition of Deep Lens...
Kroger Health, the healthcare division of the large grocery chain, announced Tuesday it had launched a clinical trial site network.
The company said it will work with trial sponsors, contract research organizations and health systems to conduct clinical trials out of select Kroger pharmacies and clinics. It will also use virtual care and digital health tools to ensure patients stay enrolled in...
In its latest dive into healthcare, Amazon is launching a generic medication subscription service through its online pharmacy.
RxPass, which will be available to Prime members, will deliver generic drugs for common conditions like high blood pressure, anxiety and acid reflux. The tech and retail giant said the service will cost a flat fee of $5 per month.
The program won't accept insurance, and...
Healthcare data analytics company Socially Determined announced a partnership with data sharing technology startup Datavant to provide life sciences companies with data on social risk drivers to improve health equity and patient outcomes.
Washington D.C.-based Socially Determined uses data to offer insights into the social determinants of health, including factors like access to food, housing...